Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value
$2.54+0.09 (+3.67%)
Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –
Alector enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alector's enterprise value was $130.71M on Nov 11, 2026, against -$138.59M a year earlier. Over the last 5 years it ranged from -$294.64M to $860.03M, with a median of -$49.19M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $130.71M | – |
| 2025 | Dec 31, 2025 | -$113.88M | – |
| 2024 | Dec 31, 2024 | -$272.11M | -429.6% |
| 2023 | Dec 29, 2023 | $82.55M | – |
| 2022 | Dec 30, 2022 | -$1.57M | -100.2% |
| 2021 | Dec 31, 2021 | $860.03M | +27.8% |
| 2020 | Dec 31, 2020 | $672.86M | -16.5% |
| 2019 | Dec 31, 2019 | $806.08M | – |
See a number that looks wrong?